You searched for "diagnostic"
International SPECTRALIS Symposium – AND BEYOND
Hemel Hempstead, Hertfordshire. UK (11 March 2025) - The International SPECTRALIS Symposium (ISS) celebrates 21 Years of Innovation in Ophthalmic Imaging at the New Heidelberg Congress Center, 13–14 June 2025, just steps away from the headquarters of Heidelberg Engineering. Recognized...TowardPi Brings Next-Generation OCT/A to the UK
TowardPi, a fast-growing leader in ophthalmic imaging, has entered the UK market with its advanced swept-source OCT (SS-OCT) and OCT angiography (OCTA) systems. Distributed exclusively by Mainline Instruments, TowardPi is already well-established in Asia and is recognised for pioneering the...Heidelberg Engineering joins the Collaborative Community on Ophthalmic Innovation (CCOI) through EssilorLuxottica’s Vision Architect membership
Heidelberg Engineering announced that it is joining the Collaborative Community on Ophthalmic Innovation (CCOI) as part of its parent company EssilorLuxottica’s Vision Architect membership – CCOI’s highest level of industry participation. CCOI is a public–private forum that convenes patients, clinicians,...
Retinoblastoma in older children
Retinoblastoma is the most common ophthalmic malignancy in childhood and over 90% are diagnosed before the age of five years. It is not often suspected in older children given its rarity and unusual clinical findings which complicates the diagnosis. The...Inherited retinal disorders now the leading cause of blindness
The recent paper in BMJ Open, from the UCL Institute of Ophthalmology, ‘A comparison of the causes of blindness certifications in England and Wales in working age adults (16-64 years), 1999-2000 with 2009-2010’ concludes that inherited retinal disorders (IRD) such...Redefining the future of sight - Moorfields Eye Charity launches first major national funding initiative
New grants strategy aims to enable innovation at scale and transform eye health. Moorfields Eye Charity has launched a significant national funding initiative to accelerate the urgent development of new eye health treatments and interventions. The new Discovery and Translation...An update on idiopathic intracranial hypertension
The incidence of Idiopathic intracranial hypertension (IIH) is increasing, likely in line with the worldwide epidemic of obesity. To date, there have been revisions in the terminology used and diagnostic criteria for IIH; these recognise the need to exclude secondary...General purpose AI: Transitioning from high performance in highly curated settings to useful applications in ophthalmology
Artificial intelligence (AI) may be understood as the ability of machines to perform tasks which otherwise require human perception, reasoning, or learning. With the advent of deep learning, AI has achieved remarkable results across a wide range of medical tasks...
